Tokyo, (March 29, 2023) — Evident Corporation ("Evident") announces that the closing date of the transfer of all shares of Evident, a specified subsidiary of Olympus, to K.K. BCJ-66, a special purpose company indirectly owned by funds advised by Bain Capital Private Equity, LP (together with its affiliates, “Bain Capital”) has been scheduled for April 3, 2023.

Reasons for postponement of the closing of the transfer

The transfer is subject to certain conditions including obtainment of approvals from relevant authorities pursuant to the competition laws and related laws and regulations of Japan and other relevant jurisdictions. Due to the expectation that additional time is needed to obtain such approvals in certain countries, the closing date of the transfer has been postponed.

Since Olympus and Bain Capital have completed all the necessary procedures for the transfer, it is decided that the closing date of the transfer to be changed from March 2023 (scheduled) to April 3, 2023.

About EVIDENT

In 2022, Olympus Corporation spun off its Scientific Solutions Division, which included its life science and industrial solutions businesses, to establish a new company called Evident. Although our name is different, our expertise, manufacturing capabilities, and commitment to our customers, which defined us over the past 100 years, remain unchanged.

At Evident, innovation and exploration are at the heart of what we do. Committed to making people’s lives healthier, safer, and more fulfilling, we support our customers with solutions that solve their challenges and advance their work; whether it’s researching medical breakthroughs, inspecting infrastructure, or exposing hidden toxins in consumer products.

Evident’s industrial solutions range from microscopes and videoscopes to nondestructive testing equipment and X-ray analyzers for maintenance, manufacturing, and environmental applications. Backed by state-of-the-art technologies, Evident products are widely used for quality control, inspection, and measurement.

In life science, Evident empowers scientists and researchers through collaboration and cutting-edge solutions. We’re dedicated to meeting the challenges and supporting the evolving needs of our customers, continuing to advance a comprehensive range of microscopes for pathology, hematology, IVF, and other clinical applications as well as for research and education.

For more information, visit EvidentScientific.com.